BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1732282)

  • 1. HLA type is not indicative for the effect of thymectomy in myasthenia gravis.
    Kuks JB; Lems SP; Oosterhuis HJ
    J Neuroimmunol; 1992 Feb; 36(2-3):217-24. PubMed ID: 1732282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HLA antigens and susceptibility to myasthenia gravis.
    Matej H; Nowakowska B; Kałamarz M; Paradowski B; Podemski R; Brzecki A
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):795-801. PubMed ID: 3508039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of HLA antigens with myasthenia gravis in Chinese on Taiwan.
    Chiu HC; Hsieh RP; Hsieh KH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1990 Feb; 23(1):12-8. PubMed ID: 2394179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-A, -B, -DR and -DQ allele and haplotype frequencies in the Moroccan population: a general population study.
    Brick C; Bennani N; Atouf O; Essakalli M
    Transfus Clin Biol; 2006 Dec; 13(6):346-52. PubMed ID: 17306585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [HLA genomic tissue typing in myasthenic patients with rheumatoid arthritis].
    Varga E; Varga E; Jáger R; Petró A; Gyódi E; Bálint G; Náfrádi L; Varga L
    Orv Hetil; 2001 Oct; 142(41):2255-7. PubMed ID: 11760469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of HLA on long-term outcome after thymectomy for myasthenia gravis.
    Machens A; Löliger C; Pichlmeier U; Emskötter T; Busch C; Izbicki JR
    J Neuroimmunol; 1998 Aug; 88(1-2):177-81. PubMed ID: 9688339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA antigens in Italian multiple sclerosis patients.
    La Mantia L; Illeni MT; Milanese C; Salmaggi A; Eoli M; Pellegris G; Nespolo A
    Ital J Neurol Sci; 1991 Feb; 12(1):81-6. PubMed ID: 2013528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA antigens in patients with chronic inflammatory demyelinating polyneuropathy.
    van Doorn PA; Schreuder GM; Vermeulen M; d'Amaro J; Brand A
    J Neuroimmunol; 1991 May; 32(2):133-9. PubMed ID: 1849516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between HLA-A, B, DQ, and DR antigens and asbestos-induced lung disease.
    Shih JF; Hunninghake GW; Goeken NE; Galvin JR; Merchant JA; Schwartz DA
    Chest; 1993 Jul; 104(1):26-31. PubMed ID: 8325081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA antigen-sharing in couples with repeated spontaneous abortions and the birthweight of babies in successful pregnancies.
    Reznikoff-Etievant MF; Bonneau JC; Alcalay D; Cavelier B; Touré C; Lobet R; Netter A
    Am J Reprod Immunol; 1991 Jan; 25(1):25-7. PubMed ID: 2029329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Subgroups of myasthenia gravis. Association of the early form with HLA B8/DR3].
    Scherbaum WA; Schumm F
    Dtsch Med Wochenschr; 1983 Aug; 108(31-32):1218. PubMed ID: 6575909
    [No Abstract]   [Full Text] [Related]  

  • 12. Histocompatibility profile of selected Latin American countries.
    Santiago-Delpín EA
    Transplant Proc; 1991 Apr; 23(2):1861-4. PubMed ID: 2053180
    [No Abstract]   [Full Text] [Related]  

  • 13. HLA-DRB1*03 and DQB1*0302 associations in a subset of patients severely affected with systemic lupus erythematosus from western India.
    Shankarkumar U; Ghosh K; Badakere SS; Mohanty D
    Ann Rheum Dis; 2003 Jan; 62(1):92-3. PubMed ID: 12480686
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antigens of histocompatibility in children with myasthenia gravis].
    Neretin VIa; Serova LD; Agafonov BV; Tsuman VG; Gekht BM; Sidorova OP; Nalivkin AE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(7):44-8. PubMed ID: 11523395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA antigens in Japanese patients with myasthenia gravis.
    Matsuki K; Juji T; Tokunaga K; Takamizawa M; Maeda H; Soda M; Nomura Y; Segawa M
    J Clin Invest; 1990 Aug; 86(2):392-9. PubMed ID: 1974553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA genotypes in Turkish patients with myasthenia gravis: comparison with multiple sclerosis patients on the basis of clinical subtypes and demographic features.
    Dönmez B; Ozakbas S; Oktem MA; Gedizlioglu M; Coker I; Genc A; Idiman E
    Hum Immunol; 2004 Jul; 65(7):752-7. PubMed ID: 15301866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of prognostic factors in thymectomized patients with myasthenia gravis: correlation between thymic lymphoid cell subsets and postoperative clinical course.
    Fujii N; Itoyama Y; Machi M; Goto I
    J Neurol Sci; 1991 Oct; 105(2):143-9. PubMed ID: 1721934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical subgroups and HLA antigens in Italian patients with psoriatic arthritis.
    Salvarani C; Macchioni PL; Zizzi F; Mantovani W; Rossi F; Baricchi R; Ghirelli L; Frizziero L; Portioli I
    Clin Exp Rheumatol; 1989; 7(4):391-6. PubMed ID: 2591112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA antigens, alleles, and haplotypes among African-Americans.
    Zachary AA; Leffell MS; Johnson A; Rose SM; Bias WB
    Transplant Proc; 1997 Dec; 29(8):3706. PubMed ID: 9414893
    [No Abstract]   [Full Text] [Related]  

  • 20. Identification of a novel HLA class II association with DQB1*0502 in an Italian myasthenic population.
    Baggi F; Antozzi C; Andreetta F; Confalonieri P; Ciusani E; Begovich AB; Erlich HA; Cornelio F; Mantegazza R
    Ann N Y Acad Sci; 1998 May; 841():355-9. PubMed ID: 9668258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.